Elise Stefanik (R-N.Y.), U.S. congresswoman for the 21st district in upstate New York and third highest-ranking Republican in the House of Representatives, visited independently-owned Condo Pharmacy in Plattsburgh, N.Y., last week in a show of support for the 340B contract pharmacy
…SPONSORED CONTENT
In 30 minutes, you will learn how to best manage your drug spend: from account set-up and best practices, to purchasing strategies and TPA configurations. We’ll identify the best metrics and KPIs to track. And we’ll show processes covered entities can implement to decrease
…
Federal health officials should not be allowed to craft their own plan to remedy unlawful Medicare Part B drug payments cuts for 340B hospitals since 2018, as the government has not shown how it would stop future illegal payment cuts,
…
SPONSORED CONTENT
In the dynamic world of 340B, identifying and resolving noncompliance issues can be a time-consuming task. Stakeholders can streamline, simplify, and strengthen their 340B operations with solutions from Apexus, which brings together a wealth of knowledge, from credentialing to noncompliance resolution, to help manage a smooth and successful 340B program. Since
…
A federal district judge has accepted a plan that might speed up a decision in the drug industry’s lawsuit challenging an Arkansas law that requires drug makers to honor 340B contract pharmacy arrangements.
U.S. Senior District Judge Billy Roy Wilson
…
The U.S. government and drug makers Novartis and United Therapeutics’ cross-appeals in their 340B contract pharmacy legal dispute have been set for oral arguments in October, marking the first of the closely watched lawsuits to advance to oral arguments at
…
Q: Where did you grow up?
Pittsburgh, Pennsylvania. As my team knows, I love to spot fellow ‘burgh natives in the field.
Q: Where did you go to college/graduate school?
I received my undergraduate degree from University of Michigan Honors College and my PharmD from University of Michigan. I did my postdoc fellowship with Northeastern and
…
The federal government during the past week filed responses to arguments that drug manufacturers AstraZeneca and Lilly made in federal appeals courts in their 340B contract pharmacy lawsuits.
“In enacting the 340B program, Congress was clear that drug manufacturers must
…
Medicare Part D beneficiaries were much less likely to use lower-cost, authorized generic versions of highly expensive hepatitis C drugs Harvoni and Epclusa in 2019 and 2020 than Medicaid beneficiaries, driving up costs for Part D enrollees and the Medicare
…
×
*Sign up for news summaries and alerts from 340B Report
